miR-4730 suppresses the malignant phenotypes of diffuse-type gastric cancer cells by targeting PTPN1
Abstract
Diffuse-type gastric cancer (DGC) exhibits strong metastatic capacity and unsatisfactory survival. Reliable biomarkers and underlying molecular mechanisms require further exploration. This study aims to detect miR-4730 expression in DGC, analyze its clinical correlation, investigate its influence on DGC cell phenotypes, and validate its downstream target gene, thereby providing a new biomarker for DGC. The expression of miR-4730 in DGC tissues was detected, and its correlation with clinicopathological parameters was analyzed. The prognostic implication of miR-4730 was evaluated via Kaplan-Meier survival analysis and Cox regression analysis. In vitro experiments were performed to assess the effects of miR-4730 on the proliferation, migration, and invasion of DGC cells. Bioinformatics prediction, dual-luciferase reporter assays, and rescue experiments were conducted to validate the targeting relationship between miR-4730 and PTPN1. miR-4730 was significantly downregulated in DGC tissues to 0.54-fold that of paired normal gastric tissues ( P < 0.001). Low miR-4730 expression correlated with unfavorable histological classification, advanced TNM stage, and lymph node metastasis. Reduced miR-4730 expression predicted poor overall survival for DGC patients and served as an independent prognostic factor. Functional experiments showed miR-4730 overexpression inhibited DGC cell proliferation, migration, and invasion. miR-4730 knockdown promoted these malignant cellular phenotypes. PTPN1 was a direct target of miR-4730 and was negatively regulated by this miRNA. Rescue experiments confirmed PTPN1 overexpression partially reversed the tumor-suppressive effects of miR-4730. miR-4730 suppresses malignant phenotypes of DGC cells through targeting PTPN1. The miR-4730/PTPN1 axis may provide a preliminary experimental basis for candidate prognostic biomarkers for DGC.